Kanjin Therapeutics is a biotechnology startup headquartered in Wilmington, Delaware, with operations spanning the United States and Japan. Founded in 2025, the company focuses…
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Kanjin Therapeutics →Already a subscriber? Sign in
Xcout Intel tracks Kanjin Therapeutics continuously — this profile deepens as new filings, funding, people and hiring data arrive.
Work at Kanjin Therapeutics? Claim this profile